Medication Fact Sheets
|
January 10, 2025

Antifungals 101: Uses, Types, and How They Work

Written By
Dr. Jaime Cloyd ND
Medically Reviewed by
Updated On
January 20, 2025

According to the Centers for Disease Control and Prevention, out of the millions of species of fungi, only a few hundred are capable of causing human disease. Fungi cause a variety of health conditions, ranging from mild skin rashes to more serious infections that affect the lungs, blood, or brain. Various antifungal medications are available over-the-counter or by prescription, depending on the type of medication, to help fight these infections.

This guide will explore everything you need to know about antifungals, from how they work to their various applications.

[signup]

Understanding Antifungals

Antifungals are medications specifically designed to treat fungal infections. 

What Are Antifungals?

The history of antifungal therapy dates back to the 1950s when amphotericin B (still in use today) was introduced to the medical field to treat systemic fungal infections. Over the decades, researchers have developed safer and more effective antifungal agents that target specific components of fungal cells while minimizing side effects.

Antifungals treat a range of superficial (skin) and systemic infections caused by fungus, including but not limited to:

Why Antifungals Are Essential

Fungal infections are more common than many realize, affecting over 7 million people annually in the United States alone. Globally, evidence suggests that there are 6.5 million new cases of severe fungal infections each year, resulting in approximately 3.8 million deaths.

Research shows that early initiation of antifungal medications, especially in critically ill patients, reduces the risk of invasive fungal infections – serious infections that spread beyond the initial site to other parts of the body – and lowers mortality rates.

Types of Antifungals

Antifungals come in different forms, including:

  • Topical: Applied directly to the skin or mucous membranes as creams, ointments, gels, or sprays. They are commonly used to treat superficial infections like athlete's foot, jock itch, and vaginal yeast infections. Examples of FDA-approved topical antifungals include clotrimazole and miconazole.
  • Oral: Taken as pills or liquids, oral antifungals are commonly prescribed for more severe or widespread infections. Fluconazole and terbinafine are frequently prescribed to treat conditions like nail fungus or systemic candidiasis.
  • Intravenous (IV): Reserved for serious, life-threatening infections,  IV antifungals like amphotericin B and caspofungin are administered in hospitals to treat conditions such as invasive aspergillosis or severe candidemia (a bloodstream infection caused by Candida).

Natural vs. Synthetic Antifungals

Natural antifungal agents are derived from plants, marine organisms, and microorganisms. Examples include plant compounds like carvacrol, eugenol, curcumin, and thymol, which have demonstrated antifungal effects in studies. Certain pharmaceutical agents, such as nystatin – a prescription medication derived from the bacterium Streptomyces noursei – also fall into this category.

On the other hand, synthetic antifungals are chemically synthesized in laboratories to target fungi more precisely through specific mechanisms. 

Benefits of Natural Antifungal Agents

Research has explored the potential of natural antifungal agents to address limitations associated with synthetic therapies, such as narrow-spectrum activity, toxicity, and the emergence of fungal resistance agents. Natural antifungals may offer multiple mechanisms of action, which could make it more challenging for fungi to develop resistance. For instance, compounds like curcumin and eugenol can disrupt fungal cell membranes and inhibit biofilm formation, which is a protective layer that fungi use to resist antifungal treatments.

While some natural antifungal agents have shown promising results in laboratory studies, their clinical efficacy and safety profiles may vary.

Advancements in Synthetic Antifungals

Synthetic antifungals are engineered for improved bioavailability, safety, and efficacy. These medications target specific fungal pathways, enhancing treatment success rates while reducing side effects. Recent advancements in synthetic antifungals have focused on enhancing efficacy, reducing toxicity, and overcoming resistance.

How Antifungals Work

Antifungals treat infection by either killing fungal cells (fungicidal) or stopping their growth (fungistatic). Depending on the biological pathways they target to achieve these effects, antifungals can be classified into different classes, including:

  • Polyenes: Create holes in fungal cell membranes
  • Azoles: Interfere with fungal cell membrane synthesis
  • Echinocandins: Damage the fungal cell wall
  • Allylamines: Inhibit an enzyme required to make a strong cell membrane
  • Pyrimidines: Disrupt fungal RNA and DNA synthesis

Factors Affecting Effectiveness

For antifungals to work effectively, they must be used as prescribed in accordance with FDA guidelines. Skipping doses or stopping treatment early can lead to incomplete eradication of the infection and increase the risk of developing antifungal resistance.

Several patient-specific factors can impact antifungal effectiveness, including age, overall health status, and immune system function. 

Always consult a healthcare provider for personalized treatment plans tailored to individual health needs.

Benefits and Risks of Antifungals

Now that we've discussed the types of antifungal agents and how they work, let's outline the benefits and common side effects associated with antifungal medications.

Benefits of Antifungal Treatments

The efficacy of antifungal drugs has been well-documented in clinical settings.

Antifungal medications save lives by treating severe systemic infections that could otherwise be fatal. Early intervention and effective drugs can significantly reduce mortality rates.

The efficacy of antifungal drugs for less severe, superficial infections varies depending on the specific agent and the type of infection being treated.

Significant differences in cure rates for ringworm have not been observed among various topical antifungal agents.

Oral terbinafine has demonstrated a high cure rate for onychomycosis, often exceeding 80% in clinical trials.

Uncomplicated vulvovaginal candidiasis may be effectively treated with a single dose of fluconazole, achieving a response rate of over 90% in studies.

Regular and proper antifungal use can also prevent the recurrence of infections, particularly in individuals prone to chronic fungal diseases.

Risks and Side Effects

However, antifungal therapy is not without risks. Adverse effect profiles will vary depending on the antifungal agent prescribed. Examples of common side effects associated with antifungal medications include:

Common Side Effects

  • Gastrointestinal disturbances (abdominal pain, diarrhea, nausea)
  • Headache
  • Skin rashes and itching

Severe Side Effects (Less Common)

  • Allergic reactions
  • Liver toxicity
  • Kidney dysfunction

Antifungal Resistance

Antifungal resistance refers to the ability of fungal pathogens to withstand the effects of antifungal drugs, rendering treatments less effective or ineffective. This resistance can be either intrinsic or acquired. Intrinsic resistance is a natural characteristic of certain fungal species, while acquired resistance develops through genetic mutations or adaptive responses to antifungal exposure.

Causes of antifungal resistance include: 

  • The overuse and misuse of antifungal agents in both clinical and agricultural settings 
  • The limited availability of therapeutic and safe antifungal medications
  • Climate change
  • Fungal genetic mutations
  • Biofilm formation

The prevalence of antifungal resistance varies by region and species. For example, azole resistance in Aspergillus fumigatus and multidrug resistance in Candida auris are significant concerns globally. Candida glabrata has shown increasing resistance to both azoles and echinocandins.

Combating Antifungal Resistance

The CDC has established the Antimicrobial Resistance Solutions Initiative (ARSI) to help combat the rise of antifungal resistance. They recommend the following strategies to stop the rise of resistance: 

  • Antifungal Stewardship Programs: Optimize antifungal use by incorporating rapid diagnostics, therapeutic drug monitoring, and clinical intervention teams.
  • Monitoring Trends: Track antifungal use and resistance patterns to inform public health actions.
  • Development of New Treatments: Encourage the research and development of new antifungal medications and diagnostic tools.
  • Education: Educate healthcare professionals and the public about the risks of antifungal resistance and the importance of appropriate antifungal use.
  • Good Hygiene Practices: Promote practices like frequent hand washing to prevent the spread of fungal infections.

[signup]

Key Takeaways

  • Antifungals are indispensable tools in combating fungal infections. They offer diverse treatment options and mechanisms to tackle both mild and severe diseases. 
  • However, like any medication, they come with benefits and risks, including the growing threat of resistance. 
  • By understanding antifungals and using them responsibly, we can protect our health and stay ahead of evolving fungal threats. 
  • If you suspect a fungal infection, consult a healthcare provider for accurate diagnosis and tailored treatment. 
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. About Antimicrobial Resistance Investments & Action. (2024, May 7). Centers for Disease Control and Prevention. https://www.cdc.gov/antimicrobial-resistance/programs/AR-investments.html
  2. Antifungal resistance. (2021, May 28). Cleveland Clinic. https://my.clevelandclinic.org/health/articles/21557-antifungal-resistance
  3. Antifungals. (2021, July 26). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/21715-antifungals
  4. Aref Shariati, Didehdar, M., Razavi, S., et al. (2022). Natural Compounds: A Hopeful Promise as an Antibiofilm Agent Against Candida Species. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.917787
  5. Baid, S. (2022, November 30). Combatting Antifungal Resistance. ASM. https://asm.org/Articles/2022/November/Combatting-Antifungal-Resistance
  6. Casadevall, A., Kontoyiannis, D. P., & Robert, V. (2019). On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds. MBio, 10(4). https://doi.org/10.1128/mbio.01397-19
  7. Cloyd, J. (2023, November 21). Targeting Root Causes: Functional Medicine for Chronic Sinusitis Relief. Rupa Health. https://www.rupahealth.com/post/targeting-root-causes-functional-medicine-for-chronic-sinusitis-relief
  8. Cloyd, J. (2025, January 3). Fluconazole: Uses, Dosage, and Warnings You Need to Know. Rupa Health. https://www.rupahealth.com/post/fluconazole-uses-dosage-and-warnings-you-need-to-know
  9. Cortegiani, A., Russotto, V., Maggiore, A., et al. (2016). Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database of Systematic Reviews, 2016(1), CD004920. https://doi.org/10.1002/14651858.cd004920.pub3
  10. Daglis, S. (2024, May 21). The Top Candida Symptoms and How to Reduce Them. Rupa Health. https://www.rupahealth.com/post/top-candida-symptoms-reduction
  11. Denning, D. W. (2024). Global incidence and mortality of severe fungal disease. The Lancet Infectious Diseases, 24(7). https://doi.org/10.1016/S1473-3099(23)00692-8
  12. Didehdar, M., Chegini, Z., & Shariati, A. (2022). Eugenol: A novel therapeutic agent for the inhibition of Candida species infection. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.872127
  13. Frías-De-León, M. G., Hernández-Castro, R., Conde-Cuevas, E., et al. (2021). Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination. Pharmaceutics, 13(10). https://doi.org/10.3390/pharmaceutics13101529
  14. Fungal Infection (Mycosis). (2022). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/24401-fungal-infections-mycosis
  15. Khwaza, V., & Aderibigbe, B. A. (2023). Antifungal Activities of Natural Products and Their Hybrid Molecules. Pharmaceutics, 15(12), 2673. https://doi.org/10.3390/pharmaceutics15122673
  16. Lobello Pearson, S. (2022, April 3). These 5 Popular Antifungal Creams Are Available Over the Counter. GoodRx. https://www.goodrx.com/conditions/fungal-infection/otc-antifungal-cream
  17. Marie, C., & White, T. C. (2009). Genetic basis of antifungal drug resistance. Current Fungal Infection Reports, 3(3), 163–169. https://doi.org/10.1007/s12281-009-0021-y
  18. McKeny, P. T., Nessel, T. A., & Zito, P. M. (2019, November 12). Antifungal Antibiotics. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538168/
  19. Moghadamtousi, S. Z., Kadir, H. A., Hassandarvish, P., et al. (2014). A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Research International, 2014, 186864. https://doi.org/10.1155/2014/186864
  20. Nystatin. ScienceDirect. https://www.sciencedirect.com/topics/neuroscience/nystatin
  21. Pappas, P. G., Kauffman, C. A., Andes, D. R., et al. (2016). Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 62(4), e1-50. https://doi.org/10.1093/cid/civ933
  22. Perfect, J. R. (2017). The antifungal pipeline: a reality check. Nature Reviews Drug Discovery, 16(9), 603–616. https://doi.org/10.1038/nrd.2017.46
  23. Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017). The global problem of antifungal resistance: prevalence, mechanisms, and management. The Lancet Infectious Diseases, 17(12), e383–e392. https://doi.org/10.1016/s1473-3099(17)30316-x
  24. Rayens, E., & Norris, K. A. (2022). Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018. Open Forum Infectious Diseases, 9(1), ofab593. https://doi.org/10.1093/ofid/ofab593
  25. Rotta, I., Ziegelmann, P. K., Otuki, M. F., et al. (2013). Efficacy of Topical Antifungals in the Treatment of Dermatophytosis. JAMA Dermatology, 149(3), 341. https://doi.org/10.1001/jamadermatol.2013.1721
  26. Sharifi-Rad, M., Varoni, E. M., Iriti, M., et al. (2018). Carvacrol and human health: A comprehensive review. Phytotherapy Research, 32(9), 1675–1687. https://doi.org/10.1002/ptr.6103
  27. Shcherbakova, L. A., Mikityuk, O. D., Arslanova, L. R., et al. (2021). Studying the Ability of Thymol to Improve Fungicidal Effects of Tebuconazole and Difenoconazole Against Some Plant Pathogenic Fungi in Seed or Foliar Treatments. Frontiers in Microbiology, 12. https://doi.org/10.3389/fmicb.2021.629429
  28. Smith, E. B. (1990). History of antifungals. Journal of the American Academy of Dermatology, 23(4 Pt 2), 776–778. https://doi.org/10.1016/0190-9622(90)70286-q
  29. Sweetnich, J. (2023, May 15). Integrative dermatology approaches to seborrheic dermatitis: Testing, diagnosis, and treatments. Rupa Health. https://www.rupahealth.com/post/integrative-dermatology-approaches-to-seborrheic-dermatitis
  30. Sweetnich, J. (2023, May 17). 3 Natural Treatments For Ringworm. Rupa Health. https://www.rupahealth.com/post/3-natural-treatments-for-ringworm
  31. Terbinafine (Oral Route). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/terbinafine-oral-route/description/drg-20066265
  32. Types of Fungal Diseases. (2024, May 3). Centers for Disease Control and Prevention. https://www.cdc.gov/fungal/about/types-of-fungal-diseases.html
  33. Vazquez, L. (2016). Antifungal Prophylaxis in Immunocompromised Patients. Mediterranean Journal of Hematology and Infectious Diseases, 8, e2016040. https://doi.org/10.4084/mjhid.2016.040
  34. Weinberg, J. L. (2023, September 25). Getting To The Root Cause of Athlete's Foot. Rupa Health. https://www.rupahealth.com/post/getting-to-the-root-cause-of-athletes-foot
  35. Zhang, M., Rao, Z., Ma, T., et al. (2022). Appropriate empirical antifungal therapy is associated with a reduced mortality rate in intensive care unit patients with invasive fungal infection: A real-world retrospective study based on the MIMIC-IV database. Frontiers in Medicine, 9, 952611. https://doi.org/10.3389/fmed.2022.952611
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.